96-22631. Manufacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 61, Number 173 (Thursday, September 5, 1996)]
    [Notices]
    [Page 46827]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-22631]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Application
    
        Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
    Regulations (CFR), this is notice that on May 13, 1996, Noramco of 
    Delaware, Inc., Division of McNeilab, Inc., 500 Old Swedes Landing 
    Road, Wilmington, Delaware 19801, made application, which was received 
    for processing on June 27, 1996, to the Drug Enforcement Administration 
    (DEA) for registration as a bulk manufacturer of the basic classes of 
    controlled substances listed below:
    
                                                                            
                               Drug                               Schedule  
                                                                            
    Codeine (9050)............................................           II 
    Oxycodone (9143)..........................................           II 
    Hydrocodone (9193)........................................           II 
    Morphine (9300)...........................................           II 
    Thebaine (9333)...........................................           II 
    Fentanyl (9801)...........................................           II 
                                                                            
    
        The firm plans to manufacture the listed controlled substances for 
    distribution to its customers as bulk product.
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the above application.
        Any such comments or objections may be addressed, in quintuplicate, 
    to the Deputy Assistant Administrator, Office of Diversion Control, 
    Drug Enforcement Administration, United States Department of Justice, 
    Washington, D.C. 20537, Attention: DEA Federal Register Representative 
    (CCR), and must be filed no later than November 4, 1996.
    
        Dated: August 21, 1996.
    Gene R. Haislip,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 96-22631 Filed 9-4-96; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
09/05/1996
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
96-22631
Pages:
46827-46827 (1 pages)
PDF File:
96-22631.pdf